Clinical Evaluation of an Innovative CaHA Bio‐Stimulator in Facial Rejuvenation: 1 Year Follow‐Up
Journal of Cosmetic Dermatology · 2025-05 · 24 (5)
DOI: 10.1111/jocd.70210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 09.05.2025. Verfasst von Giseli Petrone und 5 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Rejuvenation, Skin Aging, Durapatite, Cosmetic Techniques. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Skin aging is characterized by wrinkles, loss of elasticity, laxity, and rough texture, resulting from degenerative changes in the skin's layers. Effective treatments targeting skin structure are increasingly sought after in aesthetic medicine.
Aims
This study aimed to evaluate the safety, efficacy, and long‐term outcomes of STIIM, a novel calcium hydroxylapatite (CaHA)‐based bio‐stimulator, in facial rejuvenation. Patients/Methods Thirty‐two patients aged 35–59 received diluted CaHA injections. Outcomes were assessed through patient satisfaction surveys and objective measurements, including ultrasound evaluation of dermal thickness. Follow‐ups were conducted at 120 and 360 days post‐procedure. Safety was evaluated by monitoring adverse events.
Results
At 120 days post‐treatment, 85% of patients reported visible aesthetic improvements, and ultrasound assessments in a subset of patients demonstrated a significant 51% increase in dermal thickness, indicating improved skin structure. At 360 days, 75% of the patients continued to report aesthetic benefits, confirming the durability of the results. The treatment was well‐tolerated, with no serious adverse events reported throughout the study period.
Conclusions
This novel CaHA‐based bio‐stimulator demonstrates a safe and effective profile for facial rejuvenation, providing significant aesthetic and structural improvements with long‐lasting results. It offers a promising option for addressing the challenges of skin aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Independent Researcher, Rio de Janeiro, Brazil.
- Independent Researcher, São Paulo, Brazil.
- Independent Researcher, Minas Gerais, Brazil.
- Blanc Hospital, São Paulo, Brazil.
Zitieren
APA
Petrone, G., Leão, C., Morais, D., Ducati, E., Kasai, M., & Viana, R. (2025). Clinical Evaluation of an Innovative CaHA Bio‐Stimulator in Facial Rejuvenation: 1 Year Follow‐Up. Journal of Cosmetic Dermatology, 24(5). https://doi.org/10.1111/jocd.70210
Vancouver
Petrone G, Leão C, Morais D, Ducati E, Kasai M, Viana R. Clinical Evaluation of an Innovative CaHA Bio‐Stimulator in Facial Rejuvenation: 1 Year Follow‐Up. Journal of Cosmetic Dermatology. 2025;24(5). doi:10.1111/jocd.70210
BibTeX
@article{Petrone2025,
author = {Petrone, Giseli and Leão, Caroline and Morais, Danilo and Ducati, Eliza and Kasai, Matheus and Viana, Renata},
title = {Clinical Evaluation of an Innovative CaHA Bio‐Stimulator in Facial Rejuvenation: 1 Year Follow‐Up},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
volume = {24},
number = {5},
doi = {10.1111/jocd.70210}
}
EUVIMED